Dr. Alewine is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
37 Rockville Pike
Bldg 37
Bethesda, MD 20892Phone+1 301-496-4000
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2011 - 2014
- Johns Hopkins UniversityResidency, Internal Medicine, 2008 - 2011
- University of Maryland School of MedicineClass of 2008
Clinical Trials
Publications & Presentations
PubMed
- 89 citationsInherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapyRaffit Hassan, Betsy Morrow, Anish Thomas, Tom Walsh, Ming K. Lee
Proceedings of the National Academy of Sciences of the United States of America. 2019-04-30 - 222 citationsMesothelin Immunotherapy for Cancer: Ready for Prime Time?Raffit Hassan, Anish Thomas, Christine Alewine, Dung T. Le, Elizabeth M. Jaffee
Journal of Clinical Oncology. 2016-10-10 - 131 citationsAdvances in Anticancer Immunotoxin TherapyChristine Alewine, Raffit Hassan, Ira Pastan
The Oncologist. 2015-02-01
Press Mentions
- Can Chemo Help KRAS Inhibitors Work Better Against Pancreatic Cancer?August 20th, 2024
- New Drug Shows Promise Against Pancreatic Cancer and Breast CancerFebruary 12th, 2021
- Drug Is Promising Against Pancreatic and Breast CancersFebruary 9th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: